An essay is presented on the generic problems related similarities. It states the effects of genericness on the proliferation and distinction in the complex dynamics of the pharmaceutical companies and the similarities present in the biopharmaceutical sector. Topics discussed include kinds of similarities in the construction of generics, farmacias similares and threats and promises related to similarities.